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Caught in Between: Prescription
Drug Coverage of Medicare
Beneficiaries Near Poverty
Dennis G. Shea, Bruce C. Stuart, and Becky Briesacher
A s Congress continues to debate whether and how to add prescrip-tion drug coverage to Medicare, beneficiaries with incomes nearthe poverty level are in danger of being overlooked.These vulner-
able low-income individuals, sometimes labeled the “near-poor,” have too
much income or too many assets to qualify for public assistance, yet are still
quite needy.1 As a result, they find themselves caught between public pro-
grams that are available for the poor and private coverage that is affordable
for higher-income beneficiaries.
This is often the case with prescription drug coverage as well. Both
the House and Senate prescription drug bills currently under consideration
would provide some additional assistance to the near-poor, defined as those
with incomes between $10,000 and $20,000, but both would leave many
beneficiaries with high out-of-pocket drug costs.This Issue Brief focuses
on the current prescription drug coverage, use, and spending of the near-
poor and illustrates how the House and Senate bills would affect this
important group. Highlights of the findings include:
● Compared with other income groups, near-poor Medicare beneficiar-
ies are the least likely to have prescription drug coverage and the least
likely to retain it for the entire year. Just over half have full-year drug
coverage.
● More than one-fifth of the near-poor fill over 40 prescriptions a year.
● Nearly one of eight near-poor beneficiaries spent 10 percent or more of
their income on out-of-pocket prescription drug costs in 1999.
● In 2006, the House and Senate prescription drug proposals are projected
to reduce substantially the out-of-pocket costs of persons with income
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at 130 percent of the poverty level, from 20 per-
cent of their income to 3 to 4 percent. Neither
bill would lead to a significant reduction in the
out-of-pocket prescription drug costs for per-
sons at 160 percent of the poverty level.
Prescription Drug Coverage
In 1999, about 10.2 million Medicare beneficiaries
had incomes between $10,000 and $20,000.The
poverty level that year was $8,240 for an individ-
ual, so that 200 percent of poverty was $16,480.
For a couple, the income range for 100 to 200
percent of poverty was $11,060 to $22,120.
In 1999, near-poor Medicare beneficiaries
were less likely than poor beneficiaries and those
with incomes above $20,000 to have any prescrip-
tion drug coverage. About 62 percent of the near-
poor had coverage in December 1999, compared
with 68 percent of the poor and 70 percent of
those above the near-poor income level (Figure 1).
This group is particularly vulnerable to
interruptions in coverage. Only 55 percent of
near-poor beneficiaries had coverage for the whole
year in 1999. One-fifth (21%) of near-poor
Medicare beneficiaries with drug coverage lost that
coverage for part of the year (Figure 2).
The near-poor are also more dependent on
Medicare+Choice plans for prescription drug cov-
erage than are other income groups. In 1999, more
than one-fifth (21%) of the near-poor received
prescription drug coverage through a Medicare+
Choice plan, usually an HMO. Medicare HMOs
have become the second-most important source of
prescription drug coverage for the near-poor, after
employer-sponsored retiree coverage (Figure 3). As
our prior studies and others have shown, the qual-
ity and availability of prescription drug coverage in
these plans has eroded since the Balanced Budget
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Amendment of 1997, with dramatic declines in
coverage occurring after 2000.2 Because of their
greater reliance on those plans, the near-poor are
especially vulnerable to these declines.
Prescription Drug Use
About one-third of near-poor beneficiaries have
four or more diseases and nearly three of 10 say
that they are in fair or poor health. In general, they
are healthier than the poor but not in as good
health as those with higher incomes. Given their
health status, it is not surprising that more than
90 percent of the near-poor filled at least one pre-
scription in 1999 and that they averaged 25.1
prescriptions in the year. More than 13 percent
of near-poor Medicare beneficiaries filled over
50 prescriptions, and more than one-fifth filled over
40 prescriptions (Figure 4). On average, the near-
poor filled fewer prescriptions than the poor, but
more prescriptions than those with higher incomes.
Prescription Drug Spending
In 1999, average prescription drug spending by
the near-poor was $964, compared with $1,040
among all Medicare beneficiaries.The near-poor
may spend less than the average beneficiary because
they have less-generous coverage as well as lower
income than the average Medicare beneficiary.
Drug expenditures reached $3,000 for more than
5 percent (5.2%) of the near-poor in 1999, triple the
proportion just six years earlier (1.5%) (Figure 5).
A little more than half of the total prescrip-
tion drug expenditures of the near-poor were cov-
ered by third-party payers. As a result, this group of
Medicare beneficiaries spent more out-of-pocket
on prescription drugs than did the other income
groups (Figure 6). Out-of-pocket spending by the
near-poor increased more than 37 percent from
1993 to 1999.
Even as the percentage of the near-poor
with some prescription drug coverage rose in the
mid- to late-1990s, the number of persons with
high out-of-pocket prescription drug costs relative
to income rose. More than one-quarter (27%) of
the near-poor spent 5 percent or more of their
income on out-of-pocket prescription drug costs
in 1999. Almost one of every eight (12%) of the
near-poor spent more than 10 percent of their
income on out-of-pocket prescription drug costs
(Figure 7).3
Near-Poor Elderly Couples and
Pending Prescription Drug Legislation
A common feature of the current Medicare pre-
scription drug proposals is that the programs pro-
vide subsidies for premiums and coinsurance for
persons below or just above the poverty level.The
House bill (H.R. 1) provides a full premium sub-
sidy (for standard coverage) for persons at 135 per-
cent of poverty or below and a partial premium
subsidy for persons up to 150 percent of poverty.4
The Senate Bill (S. 1) provides a full premium sub-
sidy to persons who are under 135 percent of
poverty and a partial premium subsidy for persons
with income up to 160 percent of poverty, as long as
they are not eligible for full Medicaid coverage. Both
bills provide partial cost-sharing subsidies to persons
just above the poverty line.The House bill requires
a small copayment for each prescription, and the
Senate bill reduces the deductible and coinsurance.
Most analyses focus on an individual benefi-
ciary, but for an elderly couple trying to get along
on a very modest income, high drug costs can be
devastating. Figure 8 and the Appendix Table demon-
strate how the House and Senate bills would affect
two hypothetical elderly couples, one with annual
income that would make them eligible for a full
premium subsidy and partial cost-sharing subsidy
in either bill and one with an annual income that
would make them ineligible for premium or cost-
sharing subsidies in either of the bills.5
Assuming both husband and wife spent the
average amount on drugs that married people with-
out any drug coverage in the $10,000 to $20,000
income bracket did, and inflating this amount to
reflect recent expenditure growth, the couples
would be expected to spend $3,459 out-of-pocket
on prescription drugs in 2006.6
Under the House bill, a couple with income
at 130 percent of the poverty level would not pay
any premiums and would make only a small
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Conclusion
The near-poor are a vulnerable population and are
in need of significant help in paying for prescrip-
tion drugs. In 1999, three-quarters of this group
had some drug coverage, but more than 20 percent
had coverage for only a portion of the year.
Furthermore, this group has become increasingly
dependent on Medicare+Choice, a source of drug
coverage that has eroded dramatically in terms of
quality and availability in the last seven years.
The near-poor are just as likely as other
Medicare beneficiaries to use prescription drugs
and more likely than those with higher incomes to
be heavy users of prescription drugs.The combi-
nation of heavy use and less coverage means that
they are less protected than other income groups
from the high and rising costs of prescription
drugs. In 1999, nearly 12 percent of the near-poor
spent 10 percent or more of their income on out-
of-pocket prescription drug costs.
The prescription drug proposals passed by
the House and Senate would substantially reduce
the share of income that some near-poor couples
spend on prescription drugs. However, after the
premium and cost-sharing subsidies in both the
House and Senate bills phase out, many of the
near-poor will continue to bear significant costs.
Furthermore, in the House bill, coverage disap-
pears once individuals have spent $2,000, meaning
that even those barely above poverty could face
significant out-of-pocket costs.
Compared with other income groups,
Medicare beneficiaries just above the poverty level
suffer from poor health, scant prescription drug
coverage, and inadequate attention from policy-
makers. As the debate over adding prescription drug
coverage to Medicare continues, it is important not
to overlook this vulnerable group of beneficiaries.
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copayment ($2 for generic drugs, $5 for brand-
name drugs) for each prescription until their
spending exceeded $2,000. Above that point, they
would be responsible for all costs until their out-
of-pocket spending exceeded $3,500. If they
enrolled in the prescription drug plan, the dramati-
cally lowered cost of prescription drugs because of
insurance would increase their drug spending by
approximately 33 percent according to our estimates.
(Reduced out-of-pocket costs can be expected to
increase use of drugs; see Methodology.) Based on
this estimated level of total spending, the combina-
tion of copayments and coinsurance required
under the House bill would total $700 for this
couple, or 4.1 percent of their income.7
If the couple’s income were at 160 percent
of poverty, the House bill would offer no premium
or coinsurance subsidy. As a result, the estimated
increase in total spending if the couple chooses to
enroll in the drug plan is only 25 percent.The
combination of deductibles, coinsurance, and pre-
miums that the couple would pay would total
$2,437, or 11.6 percent of their income.
Under the Senate bill, the situation for the
couple with income at 130 percent of poverty
would be similar to that under the House bill.The
Senate bill requires individuals at this income level
to pay a $50 deductible and coinsurance of just
10 percent, as long as total spending is below $4,500.
While we estimate that the generous coverage
would increase prescription drug spending by this
couple by 44 percent, the coverage would reduce
their out-of-pocket spending to just $587, or 3.4
percent of their annual income.
The costs for the couple with income at 160
percent of the poverty level under the Senate bill
would be similar to those under the House bill. In
addition to $840 in premiums, this couple would
have to pay a $275 deductible and 50 percent of
costs, as long as total spending was under $4,500.
Total out-of-pocket spending for this couple under
the new drug plan would be $3,208, or 15.3 per-
cent of their income.
NOTES
1 T. M. Smeeding,“Nonmoney Income and the
Elderly:The Case of the ‘Tweeners’,” Journal of Policy
Analysis and Management 5 (1986): 707–24.
2 L. Achman and M. Gold, Medicare+Choice Plans
Continue to Shift More Costs to Enrollees (New York:
The Commonwealth Fund, April 2003); B.
Briesacher, B. Stuart, and D. Shea, Drug Coverage for
Medicare Beneficiaries: Why Protection May Be in
Jeopardy (New York:The Commonwealth Fund,
January 2002).
3 Data from the Medicare Current Beneficiary Survey
(MCBS) may overstate or understate the ratio of
spending to income.The MCBS collects only one
person’s prescription drug spending, but both per-
sons’ income. It does not collect data on spending or
income of other family or household members who
may share residence, expenses, and income.The
MCBS also does not collect data on premiums paid
for prescription drug insurance. Goldman and Smith
(2001) argue that the MCBS underreports household
or family income by 20 to 40 percent. Alecxih et al.
(2001) argue that the MCBS income data should be
compared with incomes of single individuals and
couples and that the MCBS data compare well with
independent estimates for single individuals, but are
somewhat lower for couples. Crystal et al. (2000)
indicate that MCBS median income is similar to esti-
mates from independent sources. On the other hand,
the MCBS also underreports prescription drug
spending (personal communication from MCBS
staff). Current estimates suggest this spending under-
reporting is 15 to 20 percent. D. Goldman and J.
Smith,“Methodological Biases in Estimating the
Burden of Out-of-Pocket Expenses,” Health Services
Research 35 (February 2001): 1357–65; L. Alecxih et
al.,“Reply,” Health Services Research 35 (February
2001): 1365–70; S. Crystal et al.,“Out-of-Pocket
Health Care Costs Among Older Americans,” The
Gerontologist 55B (January 2000): S51–S62.
4 The House bill also requires an asset means test.
5 We assume that the first couple has annual income of
$17,017, while the second couple has annual income
of $20,944.These incomes are equivalent to 130 and
160 percent of the poverty level for 2003, trended
forward to 2006 at the average annual increase in the
poverty level from 2000 to 2003.We also assume that
the couples’ spending would be similar to that of
persons in our $10,000 to $20,000 income bracket
from 1999.
6 Based on extrapolated data from the MCBS for drug
spending in 2006, we estimate that 46 percent of
near-poor persons with full-year drug coverage will
exceed $2,500 on prescription drug spending.This
suggests that as many as one-fifth of married couples
will spend more than $5,000.
7 The table assumes that drug spending in 2006 is
approximately 143 percent higher than in 1999,
based on estimates of actual and projected spending
increases from the National Health Accounts, http://
cms.hhs.gov/statistics/nhe/projections-2002/t2.asp.
We estimate the impact of each bill on the overall
spending of each couple, then estimate their share
of costs given their new level of spending and
drug coverage.
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Appendix Table. Impact of House and Senate Bills on
Out-of-Pocket Drug Spending of Near-Poor Elderly Couples by Income
Effect of H.R. 1 Effect of S. 1
Couple with Income at Couple with Income at Couple with Income at Couple with Income at
130% of Poverty Level 160% of Poverty Level 130% of Poverty Level 160% of Poverty Level
Without With Without With Without With Without With
Drug Drug Drug Drug Drug Drug Drug Drug
Coverage Coverage Coverage Coverage Coverage Coverage Coverage Coverage
Annual Income $17,017 $17,017 $20,944 $20,944 $17,017 $17,017 $20,944 $20,944
Total Drug Spending $3,459 $4,584 $3,459 $4,310 $3,459 $4,971 $3,459 $4,186
Premiums $0 $0 $0 $840 $0 $0 $0 $840
Copayments $3,459 $700 $3,459 $1,597 $3,459 $587 $3,459 $2,368
Total Out-of-Pocket
Drug Spending $3,459 $700 1 $3,459 $2,437 2 $3,459 $587 3 $3,459 $3,208 4
Out-of-Pocket Drug
Spending as a Percent
of Annual Income 20.3% 4.1% 16.5% 11.6% 20.3% 3.4% 16.5% 15.3%
1 We estimate husbands spend $2,086 and wives spend $2,498 for total spending of $4,584. Each person would pay $2 per generic prescription until they reach
total spending of $2,000. Above $2,000, each person would pay the full cost of the prescription. We estimate the couple would pay $115 in copayments under the
$2,000 threshold and $585 in spending above the threshold for a total of $700.
2 We estimate husbands spend $1,892 and wives spend $2,418 for total spending of $4,310. Each person pays a $250 deductible. Wives spend $350 on cost-
sharing for spending between $250 and $2,000 and the full $418 on spending above $2,000. Husbands spend $328 on cost-sharing for spending between $250
and $1,892.
3 We estimate husbands spend $2,096 and wives spend $2,875 for total spending of $4,971. Each person pays a $50 deductible. Husbands have $205 and
wives have $282 of cost-sharing above the deductible.
4 We estimate husbands spend $1,757 and wives spend $2,429 for total spending of $4,186. Each person pays a $275 deductible. Husbands have $741 and
wives have $1,077 of cost-sharing above the deductible.
Source: Simulation based on 1998 and 1999 Medicare Current Beneficiary Surveys.
METHODOLOGY
To estimate the effects of the current drug proposals in Congress on spending by a near-poor elderly couple,
we used data on prescription drug use and spending by persons with incomes between $10,000 and $20,000 in
1998 and 1999 from the Medicare Current Beneficiary Survey, along with other sources.The average level of
spending for persons in this group was inflated to an estimated spending level for 2006 using data on recent and
projected increases in spending on prescription drugs.We assumed that increased spending would be equally divided
between increases in utilization and increases in prices, consistent with recent research.We calculated the income
of a couple at 130 percent and 160 percent of the federal poverty level in 2003, then inflated these amounts to
2006 based upon recent trends in the poverty level.The initial ratio between spending and income was then
calculated.
We initially calculated how much the couples’ out-of-pocket spending would change if they had the basic cov-
erage outlined under each bill. For the couple at 130 percent of the poverty level, we assumed that, under the
House bill, each prescription they filled would be a generic prescription with a $2 copayment. In the other cases,
we calculated spending based upon required deductibles and coinsurance amounts. Since these reduced out-of-
pocket costs are expected to increase the use of prescription drugs, we then estimated how much total prescrip-
tion drug spending by the couple would increase. Our prior research suggests that each 10 percent reduction
in out-of-pocket costs increases total spending by 5 percent. After re-estimating the couples’ total costs, we
recalculated their out-of-pocket costs based on the bill’s features.The estimated relationship between spending
and income is then calculated as the ratio of these re-estimated out-of-pocket costs and the couples’ income.
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